New #TAPUR Study article: Cobimetinib 1 Vemurafenib in Patients With BRAF V600E-Mutant Papillary Thyroid and Biliary Tract Cancers: Results From the TAPUR Study.
Read the article. https://bit.ly/4BdD0TY
Read the article. https://bit.ly/4BdD0TY
ASCO Publications
bit.ly
October 23, 2026 at 7:00 PM
New #TAPUR Study article: Cobimetinib 1 Vemurafenib in Patients With BRAF V600E-Mutant Papillary Thyroid and Biliary Tract Cancers: Results From the TAPUR Study.
Read the article. https://bit.ly/4BdD0TY
Read the article. https://bit.ly/4BdD0TY
Cobimetinib + Vemurafenib in Patients With BRAF V600E–Mutant Papillary Thyroid and Biliary Tract #Cancers: Results From the TAPUR Study. ascopubs.org/doi/10.1200/...
ASCO Publications
ascopubs.org
October 22, 2026 at 1:12 PM
Cobimetinib + Vemurafenib in Patients With BRAF V600E–Mutant Papillary Thyroid and Biliary Tract #Cancers: Results From the TAPUR Study. ascopubs.org/doi/10.1200/...
New #TAPUR study paper: Sunitinib in Patients With Various Solid Tumors With FGFR1/2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Read the article. https://bit.ly/4jbGwb5
Read the article. https://bit.ly/4jbGwb5
October 15, 2026 at 1:00 PM
New #TAPUR study paper: Sunitinib in Patients With Various Solid Tumors With FGFR1/2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Read the article. https://bit.ly/4jbGwb5
Read the article. https://bit.ly/4jbGwb5
Sunitinib in Patients With Various Solid Tumors With FGFR1/2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. ascopubs.org/doi/10.1200/...
Sunitinib in Patients With Various Solid Tumors With FGFR1/2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study | JCO Precision Oncology
PURPOSETAPUR is a phase II basket trial evaluating the antitumor activity of commercially
available targeted agents in patients with advanced cancer and genomic alterations.
Results of two cohorts of ...
ascopubs.org
October 8, 2026 at 10:59 AM
Sunitinib in Patients With Various Solid Tumors With FGFR1/2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. ascopubs.org/doi/10.1200/...
This #TAPUR Study provides new information on the efficacy of palbociclib in heavily pretreated patients with ovarian cancer with CDKN2A alterations, warranting further study.
Read the article. https://bit.ly/4rkBMSf
#gynonc
Read the article. https://bit.ly/4rkBMSf
#gynonc
September 24, 2026 at 4:00 PM
This #TAPUR Study provides new information on the efficacy of palbociclib in heavily pretreated patients with ovarian cancer with CDKN2A alterations, warranting further study.
Read the article. https://bit.ly/4rkBMSf
#gynonc
Read the article. https://bit.ly/4rkBMSf
#gynonc
#JCOPO Editor-in-Chief Emeritus Dr James Ford & @ascocancer.bsky.social TAPUR Study Founding PI Dr Richard Schilsky discuss the 10-year anniversary of the Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study & its relationship w/ the journal. Listen to the podcast. https://bit.ly/4yPsiRQ
ASCO Publications
bit.ly
September 23, 2026 at 1:00 PM
#JCOPO Editor-in-Chief Emeritus Dr James Ford & @ascocancer.bsky.social TAPUR Study Founding PI Dr Richard Schilsky discuss the 10-year anniversary of the Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study & its relationship w/ the journal. Listen to the podcast. https://bit.ly/4yPsiRQ
ASCO just supercharged its landmark TAPUR trial with the first antibody-drug conjugate cohorts; opening doors for more patients with no other options. Precision medicine on the rise: www.asco.org/about-asco/p... #CancerBreakthrough #PrecisionOncology #TCSC
ASCO Expands Landmark Trial with First Antibody-Drug Conjugate Cohorts - ASCO
The American Society of Clinical Oncology (ASCO) has expanded its Targeted Agent and Profiling Utilization Registry (TAPUR™) Study with two new developments: The study added its first antibody-drug co...
www.asco.org
April 19, 2026 at 2:49 PM
ASCO just supercharged its landmark TAPUR trial with the first antibody-drug conjugate cohorts; opening doors for more patients with no other options. Precision medicine on the rise: www.asco.org/about-asco/p... #CancerBreakthrough #PrecisionOncology #TCSC
The TAPUR clinical trial seeks new uses for existing cancer drugs. Find out more here: players.brightcove.net/14498944001/...
May 6, 2025 at 1:56 PM
The TAPUR clinical trial seeks new uses for existing cancer drugs. Find out more here: players.brightcove.net/14498944001/...
Check out ASCO's grand rounds featuring the #TAPUR clinical trial. Open to all--learn more about this pragmatic trial seeking to find new uses for already approved targeted therapies and how you can take part. society.asco.org/sites/new-ww...
society.asco.org
April 11, 2024 at 2:22 PM
Check out ASCO's grand rounds featuring the #TAPUR clinical trial. Open to all--learn more about this pragmatic trial seeking to find new uses for already approved targeted therapies and how you can take part. society.asco.org/sites/new-ww...
ASCO's TAPUR study is a pragmatic clinical trial testing already approved targeted drugs in new cancer types. Great example of maximizing the benefits of drugs already on the market. society.asco.org/research-dat...
Targeted Agent & Profiling Utilization Registry (TAPUR) Study
The primary objective of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study is to describe the anti-tumor activity and toxicity of Food and Drug Administration (FDA)-approved, targete...
society.asco.org
March 29, 2024 at 4:43 PM
ASCO's TAPUR study is a pragmatic clinical trial testing already approved targeted drugs in new cancer types. Great example of maximizing the benefits of drugs already on the market. society.asco.org/research-dat...
Neal Meropol named PI of ASCO's TAPUR study
(@ascocancer.bsky.social)
https://cancerletter.com/in-brief/20260227_7b/
(@ascocancer.bsky.social)
https://cancerletter.com/in-brief/20260227_7b/
Neal Meropol named PI of ASCO’s TAPUR study - The Cancer Letter
Neal J. Meropol was named principal investigator of the American Society of Clinical Oncology’s Targeted Agent and Profiling Utilization Registry study. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login […]
cancerletter.com
March 2, 2026 at 2:00 PM
Neal Meropol named PI of ASCO's TAPUR study
(@ascocancer.bsky.social)
https://cancerletter.com/in-brief/20260227_7b/
(@ascocancer.bsky.social)
https://cancerletter.com/in-brief/20260227_7b/
Richard Schilsky leaves role as PI of ASCO’s TAPUR study
https://cancerletter.com/in-brief/20250905_10b/
https://cancerletter.com/in-brief/20250905_10b/
Richard Schilsky leaves role as PI of ASCO’s TAPUR study - The Cancer Letter
Richard L. Schilsky has left his role as inaugural principal investigator of the American Society of Clinical Oncology-led Targeted Agent and Profiling Utilization Registry study after a decade of leadership. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored […]
cancerletter.com
September 8, 2025 at 1:00 PM
Richard Schilsky leaves role as PI of ASCO’s TAPUR study
https://cancerletter.com/in-brief/20250905_10b/
https://cancerletter.com/in-brief/20250905_10b/
November 1, 2024 at 10:25 AM
Tupur Tapur.
Bangla.
Bangla.
August 17, 2019 at 8:31 AM
Tupur Tapur.
Bangla.
Bangla.
Russia has deployed advanced air defense systems to Venezuela…
youtube.com/watch?v=pKBy...
youtube.com/watch?v=pKBy...
U.S. SHOCKED — Russia Deploys Air Defense Power in Venezuela
YouTube video by TAPUR UPDATE
youtube.com
November 6, 2025 at 6:05 PM
Russia has deployed advanced air defense systems to Venezuela…
youtube.com/watch?v=pKBy...
youtube.com/watch?v=pKBy...
From Chaos to Stability: How Russia Is Reshaping Life in Eastern Ukraine - YouTube
www.youtube.com/watch?v=LSDD...
www.youtube.com/watch?v=LSDD...
From Chaos to Stability: How Russia Is Reshaping Life in Eastern Ukraine
YouTube video by TAPUR UPDATE
www.youtube.com
December 30, 2025 at 9:24 AM
From Chaos to Stability: How Russia Is Reshaping Life in Eastern Ukraine - YouTube
www.youtube.com/watch?v=LSDD...
www.youtube.com/watch?v=LSDD...
Ukraine can either: 1) cede land in exchange for peace, or
2) lose both land and peace. It's cruel of NATO to insist that Ukraine choose the latter!
www.youtube.com/watch?v=i1oG...
2) lose both land and peace. It's cruel of NATO to insist that Ukraine choose the latter!
www.youtube.com/watch?v=i1oG...
Inside the Warzone: How Russian Stability Shapes Life for Civilians
YouTube video by TAPUR UPDATE
www.youtube.com
December 13, 2025 at 4:17 PM
Ukraine can either: 1) cede land in exchange for peace, or
2) lose both land and peace. It's cruel of NATO to insist that Ukraine choose the latter!
www.youtube.com/watch?v=i1oG...
2) lose both land and peace. It's cruel of NATO to insist that Ukraine choose the latter!
www.youtube.com/watch?v=i1oG...
No, just an anti-fascist fighting against a false hero named ZELENSKY... www.youtube.com/watch?v=i1oG...
Inside the Warzone: How Russian Stability Shapes Life for Civilians
YouTube video by TAPUR UPDATE
www.youtube.com
December 13, 2025 at 1:28 PM
No, just an anti-fascist fighting against a false hero named ZELENSKY... www.youtube.com/watch?v=i1oG...